EUVIMEDEUVIMED entdecken
Open Access

Avoidant or Restrictive Food Intake Disorder Symptoms in Adults With Systemic Sclerosis: A Nationwide Study in Spain

Luis G Alcala-Gonzalez iD, Helen Burton-Murray, Micaela Atkins, Alfredo Guillen-Del-Castillo iD, Carolina Malagelada iD, Michael Hughes iD, Zsuzsanna H McMahan iD, Carmen P Simeón-Aznar iD

Arthritis Care & Research · 2025

DOI: 10.1002/acr.25569 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Arthritis Care & Research, 2025. Verfasst von Luis G Alcala-Gonzalez und 7 weiteren Autor:innen. Beteiligte Einrichtung: Digestive System Research Unit, Digestive Diseases Department, Vall d'Hebron University Hospital, Barcelona, Spain. Hauptthemen laut MEDLINE: Scleroderma, Systemic, Avoidant Restrictive Food Intake Disorder, Feeding and Eating Disorders. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, NIAMS NIH HHS, NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Patients with systemic sclerosis (SSc) may restrict food intake to manage their symptoms (particularly gastrointestinal [GI]). Whether some patients may develop nutritional and/or quality‐of‐life impairments indicative of an eating disorder, avoidant or restrictive food intake disorder (ARFID), is unknown. We aimed to (1) identify the prevalence and characteristics of ARFID symptoms in patients with SSc and (2) explore the relationship among ARFID symptoms, GI symptom burden, and health‐related quality of life.

Methods

In a cross‐sectional internet survey nationwide in Spain, patients with SSc completed the Spanish Nine‐Item ARFID Screen and assessments of gastrointestinal symptom burden (University of California Los Angeles Scleroderma Clinical Trial Consortium GI tract 2.0 [UCLA SCTC GIT 2.0]) and health‐related quality of life (12‐item Short Form Survey [SF‐12]).

Results

Of 200 patients with SSc, 99 patients (49.5%) screened positive for ARFID. Just over half of those who screened positive for ARFID (n = 53) screened positive based on having a fear of aversive consequences around eating (eg, GI discomfort). A positive ARFID screen was associated with a greater frequency of self‐reported enteral nutrition, weight loss, and self‐initiated (vs provider‐monitored) diet restrictions. ARFID symptoms were moderately associated with worse GI symptom severity by UCLA GIT 2.0 total score (r = 0.408, P < 0.001) but not for the reflux subscale (r = 0.058, P = 0.420) and constipation subscale (r = 0.090, P = 0.209) and with worse health‐related quality of life in all domains and both the physical and mental components of the SF‐12 (all P < 0.05).

Conclusion

ARFID symptoms were relatively common in patients with SSc. Future research is needed to identify when a positive screen for ARFID reflects an adaptive response to disease or pathologic restriction indicative of ARFID warranting behavioral treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Scleroderma, SystemicAvoidant Restrictive Food Intake DisorderFeeding and Eating DisordersHumansMaleFemaleCross-Sectional StudiesSpainMiddle AgedQuality of LifeAgedAdultPrevalence

Autor:innen und Institutionen

  • Digestive System Research Unit, Digestive Diseases Department, Vall d'Hebron University Hospital, Barcelona, Spain.
  • Massachusetts General Hospital and Harvard Medical School, Boston.
  • Systemic Autoimmune Diseases Unit, Internal Medicine Department, Vall d'Hebron University Hospital, Barcelona, Spain.
  • Digestive System Research Unit, Digestive Diseases Department, Vall d'Hebron University Hospital, Centro de Investigación Biomédica en Red Enfermedades Hepáticas y Digestivas, and Department of Medicine, Universitat Aut…
  • Division of Musculoskeletal and Dermatological Sciences, The University of Manchester and Manchester Academic Health Science Centre, Manchester, UK, and Northern Care Alliance NHS Foundation Trust, Salford Care Organisa…
  • University of Texas Health Science Center at Houston.

ORCID-Profile: Luis G Alcala-Gonzalez, Alfredo Guillen-Del-Castillo, Carolina Malagelada, Michael Hughes, Zsuzsanna H McMahan, Carmen P Simeón-Aznar

Förderung

  • NIDDK NIH HHS
  • NIAMS NIH HHS
  • NIH HHS
  • Asociación Española de Gastroenterologia
  • National Institutes of Health
  • National Institute of Diabetes and Digestive and Kidney Diseases

Zitieren

APA

Alcala-Gonzalez, L. G., Burton-Murray, H., Atkins, M., Guillen-Del-Castillo, A., Malagelada, C., Hughes, M., McMahan, Z. H., & Simeón-Aznar, C. P. (2025). Avoidant or Restrictive Food Intake Disorder Symptoms in Adults With Systemic Sclerosis: A Nationwide Study in Spain. Arthritis Care & Research. https://doi.org/10.1002/acr.25569

Vancouver

Alcala-Gonzalez LG, Burton-Murray H, Atkins M, Guillen-Del-Castillo A, Malagelada C, Hughes M, et al. Avoidant or Restrictive Food Intake Disorder Symptoms in Adults With Systemic Sclerosis: A Nationwide Study in Spain. Arthritis Care & Research. 2025. doi:10.1002/acr.25569

BibTeX
@article{AlcalaGonzalez2025,
  author = {Alcala-Gonzalez, Luis G and Burton-Murray, Helen and Atkins, Micaela and Guillen-Del-Castillo, Alfredo and Malagelada, Carolina and Hughes, Michael and McMahan, Zsuzsanna H and Simeón-Aznar, Carmen P},
  title = {Avoidant or Restrictive Food Intake Disorder Symptoms in Adults With Systemic Sclerosis: A Nationwide Study in Spain},
  journal = {Arthritis Care & Research},
  year = {2025},
  doi = {10.1002/acr.25569}
}
Kostenlos starten →